Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinoma.

Di Tommaso L, Destro A, Seok JY, Balladore E, Terracciano L, Sangiovanni A, Iavarone M, Colombo M, Jang JJ, Yu E, Jin SY, Morenghi E, Park YN, Roncalli M.

J Hepatol. 2009 Apr;50(4):746-54. doi: 10.1016/j.jhep.2008.11.014. Epub 2008 Dec 25.

PMID:
19231003
[PubMed - indexed for MEDLINE]
2.

Annexin A2 as a differential diagnostic marker of hepatocellular tumors.

Longerich T, Haller MT, Mogler C, Aulmann S, Lohmann V, Schirmacher P, Brand K.

Pathol Res Pract. 2011 Jan 15;207(1):8-14. doi: 10.1016/j.prp.2010.09.007. Epub 2010 Oct 23.

PMID:
20971570
[PubMed - indexed for MEDLINE]
3.

Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma.

Tremosini S, Forner A, Boix L, Vilana R, Bianchi L, Reig M, Rimola J, Rodríguez-Lope C, Ayuso C, Solé M, Bruix J.

Gut. 2012 Oct;61(10):1481-7. doi: 10.1136/gutjnl-2011-301862. Epub 2012 Jan 27.

PMID:
22287594
[PubMed - indexed for MEDLINE]
4.

Diagnostic value of HSP70, glypican 3, and glutamine synthetase in hepatocellular nodules in cirrhosis.

Di Tommaso L, Franchi G, Park YN, Fiamengo B, Destro A, Morenghi E, Montorsi M, Torzilli G, Tommasini M, Terracciano L, Tornillo L, Vecchione R, Roncalli M.

Hepatology. 2007 Mar;45(3):725-34.

PMID:
17326147
[PubMed - indexed for MEDLINE]
5.

[Expression and clinicopathologic significance of GPC3 and other antibodies in well-differentiated hepatocellular carcinoma].

DU JL, Wei LX, Wang YL.

Zhonghua Bing Li Xue Za Zhi. 2011 Jan;40(1):11-6. Chinese.

PMID:
21429352
[PubMed - indexed for MEDLINE]
6.

Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma.

Lagana SM, Salomao M, Bao F, Moreira RK, Lefkowitch JH, Remotti HE.

Appl Immunohistochem Mol Morphol. 2013 Mar;21(2):170-6. doi: 10.1097/PAI.0b013e31825d527f.

PMID:
22914605
[PubMed - indexed for MEDLINE]
7.

Diagnostic accuracy of clathrin heavy chain staining in a marker panel for the diagnosis of small hepatocellular carcinoma.

Di Tommaso L, Destro A, Fabbris V, Spagnuolo G, Laura Fracanzani A, Fargion S, Maggioni M, Patriarca C, Maria Macchi R, Quagliuolo M, Borzio M, Iavarone M, Sangiovanni A, Colombo M, Roncalli M.

Hepatology. 2011 May;53(5):1549-57. doi: 10.1002/hep.24218.

PMID:
21520170
[PubMed - indexed for MEDLINE]
8.

SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma.

Jin GZ, Yu WL, Dong H, Zhou WP, Gu YJ, Yu H, Yu H, Lu XY, Xian ZH, Liu YK, Cong WM, Wu MC.

J Hepatol. 2013 Sep;59(3):510-7. doi: 10.1016/j.jhep.2013.04.028. Epub 2013 May 9.

PMID:
23665285
[PubMed - indexed for MEDLINE]
9.

Glypican-3 expression distinguishes small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules.

Libbrecht L, Severi T, Cassiman D, Vander Borght S, Pirenne J, Nevens F, Verslype C, van Pelt J, Roskams T.

Am J Surg Pathol. 2006 Nov;30(11):1405-11.

PMID:
17063081
[PubMed - indexed for MEDLINE]
10.

Differential diagnostic value of GPC3-CD34 combined staining in small liver nodules with diameter less than 3 cm.

Wang F, Jing X, Wang T, Li G, Li T, Zhang Q, Huang Y, Li J, Wang Y, Gao Y, Han T, Du Z.

Am J Clin Pathol. 2012 Jun;137(6):937-45. doi: 10.1309/AJCP0KZZ5DSIGMNY.

PMID:
22586053
[PubMed - indexed for MEDLINE]
Free Article
11.

The clinicopathological significance of heat shock protein 70 and glutamine synthetase expression in hepatocellular carcinoma.

Shin E, Ryu HS, Kim SH, Jung H, Jang JJ, Lee K.

J Hepatobiliary Pancreat Sci. 2011 Jul;18(4):544-50. doi: 10.1007/s00534-010-0367-0.

PMID:
21234611
[PubMed - indexed for MEDLINE]
12.

Glutamine synthetase as an early marker for hepatocellular carcinoma based on proteomic analysis of resected small hepatocellular carcinomas.

Long J, Lang ZW, Wang HG, Wang TL, Wang BE, Liu SQ.

Hepatobiliary Pancreat Dis Int. 2010 Jun;9(3):296-305.

PMID:
20525558
[PubMed - indexed for MEDLINE]
Free Article
13.

Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.

Coston WM, Loera S, Lau SK, Ishizawa S, Jiang Z, Wu CL, Yen Y, Weiss LM, Chu PG.

Am J Surg Pathol. 2008 Mar;32(3):433-44. doi: 10.1097/PAS.0b013e318158142f.

PMID:
18300806
[PubMed - indexed for MEDLINE]
14.

Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.

Anatelli F, Chuang ST, Yang XJ, Wang HL.

Am J Clin Pathol. 2008 Aug;130(2):219-23. doi: 10.1309/WMB5PX57Y4P8QCTY.

PMID:
18628090
[PubMed - indexed for MEDLINE]
Free Article
15.

A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.

Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL.

Gastroenterology. 2006 Dec;131(6):1758-67. Epub 2006 Sep 19.

PMID:
17087938
[PubMed - indexed for MEDLINE]
16.

Pathology of early hepatocellular carcinoma: conventional and molecular diagnosis.

Roskams T, Kojiro M.

Semin Liver Dis. 2010 Feb;30(1):17-25. doi: 10.1055/s-0030-1247129. Epub 2010 Feb 19. Review.

PMID:
20175030
[PubMed - indexed for MEDLINE]
17.

Hepatocellular dysplastic nodules.

Roncalli M, Borzio M, Di Tommaso L.

Ann Ital Chir. 2008 Mar-Apr;79(2):81-9.

PMID:
18727269
[PubMed - indexed for MEDLINE]
18.

Proliferating cell nuclear antigen and Ki-67 labeling in hepatocellular nodules: a comparative study.

Tiniakos DG, Brunt EM.

Liver. 1999 Feb;19(1):58-68.

PMID:
9928768
[PubMed - indexed for MEDLINE]
19.

Glypican-3 is a useful diagnostic marker for a component of hepatocellular carcinoma in human liver cancer.

Shirakawa H, Kuronuma T, Nishimura Y, Hasebe T, Nakano M, Gotohda N, Takahashi S, Nakagohri T, Konishi M, Kobayashi N, Kinoshita T, Nakatsura T.

Int J Oncol. 2009 Mar;34(3):649-56.

PMID:
19212669
[PubMed - indexed for MEDLINE]
20.

A novel panel of biomarkers in distinction of small well-differentiated HCC from dysplastic nodules and outcome values.

Jin GZ, Dong H, Yu WL, Li Y, Lu XY, Yu H, Xian ZH, Dong W, Liu YK, Cong WM, Wu MC.

BMC Cancer. 2013 Mar 27;13:161. doi: 10.1186/1471-2407-13-161.

PMID:
23537217
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk